Abacus Planning Group, Inc. Vericel Corp Transaction History
Abacus Planning Group, Inc.
- $545 Million
- Q3 2024
Shares
2 transactions
Others Institutions Holding VCEL
# of Institutions
271Shares Held
48.5MCall Options Held
91.1KPut Options Held
39.8K-
Black Rock Inc. New York, NY8.06MShares$354 Million0.01% of portfolio
-
Brown Capital Management LLC Baltimore, MD4.42MShares$194 Million4.16% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.44MShares$152 Million0.0% of portfolio
-
State Street Corp Boston, MA2.48MShares$109 Million0.01% of portfolio
-
Conestoga Capital Advisors, LLC2.08MShares$91.3 Million1.21% of portfolio
About Vericel Corp
- Ticker VCEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,178,000
- Market Cap $2.08B
- Description
- Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...